Genetic Analysis awarded NOK 16 million to develop microbiome marker to aid treatment of Inflammatory Bowel Disease

In this project, GA will develop an easy to use, in vitro diagnostic test that profiles gut
microbiota to predict disease progression and treatment regimes in patients with ulcerative
colitis. The development and validation of the test will be done in close collaboration with
R&D partners at Akershus University Hospital (Prof. Stephan Brackmann), Norway and
Sahlgrenska University Hospital/University of Gothenburg (Prof. Lena Öhman), Sweden.